Male Infertility - Pipeline Review, H2 2017

Publisher Name :
Date: 12-Sep-2017
No. of pages: 38
Inquire Before Buying

Male Infertility - Pipeline Review, H2 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Male Infertility - Pipeline Review, H2 2017, provides an overview of the Male Infertility (Male Health) pipeline landscape.

Male infertility refers to a male's inability to achieve a pregnancy in a fertile female. Male infertility is caused due to low sperm production, immobile sperm, or blockages that prevent the delivery of sperm. Symptoms include pain, swelling or a lump in the testicle area. Predisposing factors include smoking tobacco, using alcohol, being overweight, being exposed to toxins, certain medical conditions, including tumors and chronic illnesses. Treatment includes surgery and hormone replacement therapy.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Male Infertility - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Male Infertility (Male Health), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Male Infertility (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 2, 4, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.

Male Infertility (Male Health) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Male Infertility (Male Health).

- The pipeline guide reviews pipeline therapeutics for Male Infertility (Male Health) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Male Infertility (Male Health) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Male Infertility (Male Health) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Male Infertility (Male Health)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Male Infertility (Male Health).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Male Infertility (Male Health) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Male Infertility - Pipeline Review, H2 2017

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Male Infertility - Overview
Male Infertility - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Male Infertility - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Male Infertility - Companies Involved in Therapeutics Development
Cadila Healthcare Ltd
Ferring International Center SA
Health Ever Bio-Tech Co Ltd
Navya Biologicals Pvt Ltd
Male Infertility - Drug Profiles
Biosimilar 2 for Diabetes, Infertility and Rheumatoid Arthritis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biosimilar 5 for Infertility and Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biosimilar 6 for Infertility, Oncology and Immunology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Biosimilar 7 for Infertility, Immunology, Infectious Disease and Oncology - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FE-999310 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LM-002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
MCS-5 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NAV-013 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PAM-8 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PKB-171 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Recombinant Beta Glucosidase 2 Replacement for Gaucher's Disease and Male Infertility - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TOP-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TOP-002 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
trequinsin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Male Infertility - Dormant Projects
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Male Infertility, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Male Infertility - Pipeline by Cadila Healthcare Ltd, H2 2017
Male Infertility - Pipeline by Ferring International Center SA, H2 2017
Male Infertility - Pipeline by Health Ever Bio-Tech Co Ltd, H2 2017
Male Infertility - Pipeline by Navya Biologicals Pvt Ltd, H2 2017
Male Infertility - Dormant Projects, H2 2017

List of Figures
Number of Products under Development for Male Infertility, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Number of Products by Targets, H2 2017
Number of Products by Stage and Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Top 10 Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017
  • Male Hypogonadism - Pipeline Insight, 2017
    Published: 28-Jul-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Male Hypogonadism-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Male Hypogonadism. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Male Hypogonadism by development stage, therapy type, route of administration and molecule type is also covered in the report. It also......
  • Male Infertility - Pipeline Insight, 2017
    Published: 28-Jul-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Male Infertility-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Male Infertility. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Male Infertility by development stage, therapy type, route of administration and molecule type is also covered in the report. It also ha......
  • Male Hypogonadism - Epidemiology Insights to 2025
    Published: 28-Jul-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight's "Male Hypogonadism -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Male Hypogonadism in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Male Hypogonadism. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Male Hypogonadism. The report contains the targeted patient populat......
  • Male Hypogonadism - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 28-Jul-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Male Hypogonadism - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Male Hypogonadism for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Male Hypogonadism . It enables understanding of th......
  • Male Hypogonadism - Pipeline Review, H2 2017
    Published: 18-Jul-2017        Price: US 2000 Onwards        Pages: 100
    Male Hypogonadism - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Male Hypogonadism - Pipeline Review, H2 2017, provides an overview of the Male Hypogonadism (Male Health) pipeline landscape. Male hypogonadism is a condition in which the body doesn't produce enough testosterone. Symptoms include fatigue, hot flashes, infertility, decrease in muscle mass and loss of bone mass (osteopo......
  • Erectile Dysfunction - Pipeline Review, H2 2017
    Published: 18-Jul-2017        Price: US 2000 Onwards        Pages: 112
    Erectile Dysfunction - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Erectile Dysfunction - Pipeline Review, H2 2017, provides an overview of the Erectile Dysfunction (Male Health) pipeline landscape. Erectile dysfunction, or ED, is the inability of a man to have an erection hard enough to have sexual intercourse. It can also be known as impotence. The predisposing factors include to......
  • Erectile Dysfunction - Pipeline Insight, 2017
    Published: 05-Jul-2017        Price: US 1500 Onwards        Pages: 70
    DelveInsight's, " Erectile Dysfunction -Pipeline Insights, 2017", report provides comprehensive insights about pipeline drugs across this Erectile Dysfunction. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Erectile Dysfunction. This report provides information on the therapeutic development for Erectile Dysfunction, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinica......
  • Erectile Dysfunction - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 05-Jul-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Erectile Dysfunction - Market Insights, Epidemiology and Market Forecast - 2025" Reports provides an overview of the disease and global market size of the Erectile Dysfunction for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Erectile Dysfunction forecasted market share for ten years to 2025 segmented by seven major markets. In addition, the report includes the hist......
  • Erectile Dysfunction - Epidemiology Insights to 2025
    Published: 05-Jul-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight " Erectile Dysfunction - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Erectile Dysfunction in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Erectile Dysfunction prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs